Gao Lijuan, Xia Shuang, Zhang Kunyi, Lin Chengguang, He Xuyu, Zhang Ying
Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, China.
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, China.
Transl Cancer Res. 2021 Jan;10(1):445-460. doi: 10.21037/tcr-19-2888.
The aim of this study was to identify downstream target genes and pathways regulated by THZ1 in nasopharyngeal carcinoma (NPC).
The gene expression profile of GSE95750 in two NPC cell lines, untreated group and treated with THZ1 group, was analyzed. Differentially expressed genes (DEGs) were compared using the R-software. Then Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathways (KEGG) was analyzed using Database for Annotation, Visualization, and Integrated Discovery (DAVID). Cytoscape was used for protein-protein interaction (PPI) analysis. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to verified the gene expression.
We identified 25 genes with increased expression and 567 genes with decreased expression in THZ1-treated NPC cells. The top 10 significantly DEGs between untreated group and THZ1 treated group were identified by qRT-PCR and the results were in agreement with RNA-seq. The total 592 DEGs were found enriched in 1,148 GO terms and 38 KEGG pathways. The most important enriched pathways identified were cell cycle related, and several related node genes were identified, such as , , , , , , , , , , and family, which consistent with RNA-seq.
Our results emphasize the differential genes and pathways occurring in THZ1-treated NPC cells, which increases our understanding of the anti-tumor mechanisms of THZ1.
本研究旨在鉴定噻唑烷二酮类化合物1(THZ1)在鼻咽癌(NPC)中调控的下游靶基因和信号通路。
分析了GSE95750在两种NPC细胞系(未处理组和THZ1处理组)中的基因表达谱。使用R软件比较差异表达基因(DEG)。然后使用注释、可视化和综合发现数据库(DAVID)分析基因本体(GO)和京都基因与基因组百科全书通路(KEGG)。使用Cytoscape进行蛋白质-蛋白质相互作用(PPI)分析。采用定量逆转录聚合酶链反应(qRT-PCR)验证基因表达。
我们在THZ1处理的NPC细胞中鉴定出25个表达增加的基因和567个表达降低的基因。通过qRT-PCR鉴定了未处理组和THZ1处理组之间前10个显著差异表达基因,结果与RNA测序一致。总共592个差异表达基因在1148个GO术语和38条KEGG通路中富集。鉴定出的最重要的富集通路与细胞周期相关,并鉴定了几个相关的节点基因,如 、 、 、 、 、 、 、 、 、 、 家族,这与RNA测序结果一致。
我们的结果强调了THZ1处理的NPC细胞中出现的差异基因和信号通路,这增加了我们对THZ1抗肿瘤机制的理解。